65 filings
Page 3 of 4
8-K
00qram d0uq8
7 Nov 19
Jounce Therapeutics Reports Third Quarter 2019 Financial Results
6:43am
8-K
zw06b7djxor tak
4 Sep 19
Regulation FD Disclosure
8:51am
8-K
pprp75f
7 Aug 19
Jounce Therapeutics Reports Second Quarter 2019 Financial Results
7:16am
8-K
v1nap9srzrw38
23 Jul 19
Entry into a Material Definitive Agreement
4:05pm
8-K
gl8iusdumf1rjqlts4
13 Jun 19
Submission of Matters to a Vote of Security Holders
10:27am
8-K
tl0prlwgltsthe8
8 May 19
Jounce Therapeutics Reports First Quarter 2019 Financial Results
7:12am
8-K
0muen04y61pjazbl
6 Mar 19
Jounce Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
7:19am
8-K
l9x 3g88d
7 Jan 19
Results of Operations and Financial Condition
8:04am
8-K
3dfa 1zzdcmnuiifk
13 Nov 18
Jounce Therapeutics Reports Third Quarter 2018 Financial Results
7:06am
8-K
zcq42fvx8wr6
9 Nov 18
Regulation FD Disclosure
8:07am
8-K
cvr enf5qb7q9g
9 Aug 18
Jounce Therapeutics Reports Second Quarter 2018 Financial Results
7:20am
8-K
cvyfg5ybx rxrwpftw
22 Jun 18
Submission of Matters to a Vote of Security Holders
4:49pm
8-K
05z3uo9j 5mc8840b7l7
5 Jun 18
Regulation FD Disclosure
12:00am
8-K
v86yy36k6 19
4 Jun 18
Jounce Therapeutics Presents Preliminary Efficacy Data from Ongoing Phase 1/2 ICONIC Trial of JTX-2011 in Patients with Advanced Cancers
12:00am
8-K
cp1 yoizfz8bt00zvhl
9 May 18
Jounce Therapeutics Reports First Quarter 2018 Financial Results
7:25am
8-K
bwje2w6l00xepvnt
8 Mar 18
Jounce Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
gdijy2yg
8 Jan 18
Results of Operations and Financial Condition
12:00am
8-K
b57t h4n75mhq
13 Nov 17
Jounce Therapeutics Reports Third Quarter 2017 Financial Results
12:00am
8-K
cg4mgzomtm8l3asgn5lv
23 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
0fafz
9 Aug 17
Jounce Therapeutics Reports Second Quarter 2017 Financial Results
12:00am